The #1 Advantage for THA or TKA Tele-Rehabilitation

New work presented at the 2019 Annual Meeting of the American Academy of Orthopaedic Surgeons has found that tele-rehabilitation doesn’t have to mean that patients end up back in the hospital.

The study, “Tele-Rehabilitation for Total Hip and Knee Arthroplasty Patients: No Increase in Readmissions,” followed 40 patients who underwent total hip arthroplasty (THA) and total knee arthroplasty (TKA) but then, in addition to four to six traditional/face-to-face physical therapy sessions, did rehab sessions at home with an animated avatar called VERA (virtual exercise rehabilitation assistant).

The tele-rehabilitation patient outcomes were compared to 614 patients who were discharged to home and underwent home or outpatient physical therapy following THA or TKA.

The tele-rehabilitation group had essentially the same low 30 day to 90-day readmission rates that were recorded for patients that had traditional home or outpatient physical therapy.

The tele-rehab group had the following readmission statistics—30 day, 2.5% vs. 4.2% (for traditional rehab patients); 90 day, 2.5% vs. 5.7% (traditional).

The researchers also found that there was a near identical rate of emergency department visits at 90 days (tele-rehabilitation, 10%; traditional, 9.8%).

Among the research findings:

  • Patients had high rates of accuracy in performing exercises—93% for the TKA group and 90% for the THA group.
  • None of the TKA tele-rehabilitation patients required manipulation.
  • Cost analysis showed a minimum cost savings of $1,000 with tele-rehabilitation.

By Elizabeth Hofheinz, M.P.H., M.Ed. | Orthopedics This Week

Image Credit: Reflexion Health

READ MORE

About Peter Coffaro 504 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.